Tiriveedhi, V.; Ivy, M.T.; Myles, E.L.; Zent, R.; Rathmell, J.C.; Titze, J.
Ex Vivo High Salt Activated Tumor-Primed CD4+T Lymphocytes Exert a Potent Anti-Cancer Response. Cancers 2021, 13, 1690.
https://doi.org/10.3390/cancers13071690
AMA Style
Tiriveedhi V, Ivy MT, Myles EL, Zent R, Rathmell JC, Titze J.
Ex Vivo High Salt Activated Tumor-Primed CD4+T Lymphocytes Exert a Potent Anti-Cancer Response. Cancers. 2021; 13(7):1690.
https://doi.org/10.3390/cancers13071690
Chicago/Turabian Style
Tiriveedhi, Venkataswarup, Michael T. Ivy, Elbert L. Myles, Roy Zent, Jeffrey C. Rathmell, and Jens Titze.
2021. "Ex Vivo High Salt Activated Tumor-Primed CD4+T Lymphocytes Exert a Potent Anti-Cancer Response" Cancers 13, no. 7: 1690.
https://doi.org/10.3390/cancers13071690
APA Style
Tiriveedhi, V., Ivy, M. T., Myles, E. L., Zent, R., Rathmell, J. C., & Titze, J.
(2021). Ex Vivo High Salt Activated Tumor-Primed CD4+T Lymphocytes Exert a Potent Anti-Cancer Response. Cancers, 13(7), 1690.
https://doi.org/10.3390/cancers13071690